In patients <40 years old undergoing CABG, long-term survival is limited by recurrent ischemic events, highlighting the critical need for internal mammary conduits, aspirin, lipid-lowering therapy, and strict diabetes management.
No takes yet. Share an insight, caveat, or question.
Modifiable factors associate with late mortality after CABG in patients <40; supports targeted secondary prevention but leaves open need for prospective confirmation.
French et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: